Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nutriband Equity Warrant Exp 30th Sep 2026 NTRBW

Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its... see more

Recent & Breaking News (NDAQ:NTRBW)

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

Accesswire March 25, 2024

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

Accesswire March 4, 2024

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

Accesswire January 29, 2024

Nutriband CEO Publishes Letter to Shareholders

Accesswire January 26, 2024

Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch

Accesswire January 5, 2024

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

Accesswire November 28, 2023

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

Accesswire November 8, 2023

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales 0f $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

Accesswire October 11, 2023

Nutriband Unveils Groundbreaking Innovation in Transdermal Medications

TheNewsWire September 20, 2023

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Accesswire September 20, 2023

Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

Accesswire September 12, 2023

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Accesswire September 11, 2023

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

Accesswire August 30, 2023

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

TheNewsWire July 27, 2023

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

Accesswire July 14, 2023

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

Accesswire June 23, 2023

Nutriband to Attend 2023 BIO International Convention

Accesswire May 10, 2023

Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023

Accesswire April 27, 2023

Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023

Accesswire April 19, 2023

Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development

Accesswire April 4, 2023